translation agency

NLM AIDSLINE
The lung in the immunocompromised patient. Infectious complications part 2.
Tamm M; Division of Pneumology, University Hospital Basel, Switzerland.;
November 30, 1999
Unique Identifier : AIDSLINE MED/99294838

Pulmonary infections decisively contribute to morbidity and mortality in immunocompromised patients. Bacterial, mycobacterial and infections with Pneumocystis carinii have been reviewed in an article in the last issue of Respiration. In this review, viral and fungal pulmonary infections are discussed in HIV-positive patients and in patients treated with high-dose chemotherapy, stem cell or solid-organ transplantation.

JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Drug Therapy/ADVERSE EFFECTS Human HIV Seropositivity/COMPLICATIONS Immunocompromised Host/*PHYSIOLOGY Lung Diseases/*ETIOLOGY Mycoses/*ETIOLOGY Organ Transplantation Postoperative Complications Stem Cells/TRANSPLANTATION Virus Diseases/*ETIOLOGY

www.aegis.org